WO2011095985A3 - Rasagiline salts and processes for the preparation thereof - Google Patents
Rasagiline salts and processes for the preparation thereof Download PDFInfo
- Publication number
- WO2011095985A3 WO2011095985A3 PCT/IN2011/000059 IN2011000059W WO2011095985A3 WO 2011095985 A3 WO2011095985 A3 WO 2011095985A3 IN 2011000059 W IN2011000059 W IN 2011000059W WO 2011095985 A3 WO2011095985 A3 WO 2011095985A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- processes
- preparation
- rasagiline salts
- rasagiline
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention relates to crystalline salts of rasagiline and processes for the preparation thereof. The invention also relates to pharmaceutical compositions comprising the same.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN242MU2010 | 2010-02-02 | ||
IN242/MUM/2010 | 2010-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011095985A2 WO2011095985A2 (en) | 2011-08-11 |
WO2011095985A3 true WO2011095985A3 (en) | 2011-12-22 |
Family
ID=44355887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2011/000059 WO2011095985A2 (en) | 2010-02-02 | 2011-01-28 | Rasagiline salts and processes for the preparation thereof |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011095985A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU231054B1 (en) * | 2010-11-18 | 2020-04-28 | Egis Gyógyszergyár Nyrt. | Novel salts suitable for the preparation of pharmaceutical compositions |
EP2705021A2 (en) | 2011-05-04 | 2014-03-12 | Cadila Healthcare Limited | Rasagiline and its pharmaceutically acceptable salts |
DE102012000786A1 (en) | 2012-01-18 | 2013-07-18 | Stada Arzneimittel Ag | Process for the preparation of a solid pharmaceutical composition containing the active substance rasagiline |
CN111983075A (en) * | 2020-08-17 | 2020-11-24 | 重庆华森制药股份有限公司 | Method for detecting rasagiline and enantiomer thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532415A (en) * | 1990-01-03 | 1996-07-02 | Teva Pharmaceutical Industries Ltd. | R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
US6959060B2 (en) * | 2000-08-31 | 2005-10-25 | Lg Electronics Inc. | Jitter reducing apparatus using digital modulation technique |
CN1911211A (en) * | 2006-08-25 | 2007-02-14 | 重庆医药工业研究院有限责任公司 | Solid oral prepn. of leishajilan |
CN101600346A (en) * | 2006-12-14 | 2009-12-09 | 泰华制药工业有限公司 | The tannate of Rasagiline |
-
2011
- 2011-01-28 WO PCT/IN2011/000059 patent/WO2011095985A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5532415A (en) * | 1990-01-03 | 1996-07-02 | Teva Pharmaceutical Industries Ltd. | R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses thereof |
US6959060B2 (en) * | 2000-08-31 | 2005-10-25 | Lg Electronics Inc. | Jitter reducing apparatus using digital modulation technique |
CN1911211A (en) * | 2006-08-25 | 2007-02-14 | 重庆医药工业研究院有限责任公司 | Solid oral prepn. of leishajilan |
CN101600346A (en) * | 2006-12-14 | 2009-12-09 | 泰华制药工业有限公司 | The tannate of Rasagiline |
Also Published As
Publication number | Publication date |
---|---|
WO2011095985A2 (en) | 2011-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011098582A3 (en) | Novel crystalline forms of ivabradine hydrochloride | |
WO2011130615A3 (en) | Preparation of lacosamide | |
WO2014014835A8 (en) | Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
WO2010092090A3 (en) | Novel salts of sitagliptin | |
WO2012068441A3 (en) | Intedanib salts and solid state forms thereof | |
WO2012042371A3 (en) | Pharmaceutical composition | |
ZA201206254B (en) | Novel salts for the manufacture of pharmaceutical compositions | |
WO2011138281A3 (en) | Process for the preparation of dithiine tetracarboxydiimides | |
WO2011157720A3 (en) | Ivabradine-containing pharmaceutical composition with modified release | |
WO2012021715A3 (en) | Stable formulations of linaclotide | |
WO2012070062A3 (en) | Novel polymorph of nilotinib hydrochloride | |
WO2014072961A3 (en) | Polymorphic forms of suvoroxant | |
WO2012037562A3 (en) | Pharmaceutical and nutraceutical compositions of abscisic acid | |
WO2013134534A3 (en) | Solid state forms of cabazitaxel and processes for preparation thereof | |
WO2013055684A8 (en) | Rasagiline citramide | |
WO2011136905A3 (en) | Crystalline peptide epoxyketone immunoproteasome inhibitor | |
EA029539B8 (en) | Pharmaceutical composition of sitagliptin | |
MX2014010433A (en) | Novel crystalline form of sitagliptin sulfate. | |
WO2012137227A3 (en) | Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof | |
WO2010008735A3 (en) | Solid states of o-desmethylvenlaf axine salts | |
WO2014068586A3 (en) | Solid oral compositions of tolvaptan | |
WO2013128379A3 (en) | Crystalline polymorphic forms of linagliptin | |
WO2010006904A3 (en) | Crystalline forms of rabeprazole sodium | |
WO2011107866A3 (en) | Silyl-derivatives of polysaccharides | |
WO2011095985A3 (en) | Rasagiline salts and processes for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11739499 Country of ref document: EP Kind code of ref document: A2 |